Cluster analysis of deterioration sites after first-line epidermal growth factor receptor-tyrosine kinase inhibitor in epidermal growth factor receptor mutated non-small cell lung cancer

INTRODUCTION: For epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC), no studies have treated the site of recurrence after first-line tyrosine kinase inhibitor (TKI) treatment as a “metastasis pattern”. This study aims to assess whether these patients have a specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Okauchi, Shinichiro, Miyazaki, Kunihiko, Satoh, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319187/
https://www.ncbi.nlm.nih.gov/pubmed/35903205
http://dx.doi.org/10.5114/wo.2022.118195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319187/
https://www.ncbi.nlm.nih.gov/pubmed/35903205
http://dx.doi.org/10.5114/wo.2022.118195

Ejemplares similares